Sign In
Buy TMO
$473.95
-8.13 (-1.69%)
At Close: Jun 03, 2026
Thermo Fisher added to Goldman's 'Conviction Buy' list
01:58pm, Friday, 24'th Sep 2021
The "Halftime Report" traders debate Goldman's bullish call on Thermo Fisher.
Quality Growth Stocks That Gurus Love
05:31pm, Thursday, 23'rd Sep 2021
It's rare for a stock to be able to achieve average annual returns above 20% for an entire decade. It's even more rare to do so while the company is consistently growing its top and bottom lines and m
Final Trades: American Express, Live Nation, Thermo Fisher & more
02:11pm, Thursday, 23'rd Sep 2021
The "Halftime Report" traders give their top picks to watch for the second half. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNBC TV:
Thermo Fisher Scientific to Present at the JP Morgan 12th Annual U.S. All Stars Conference on September 22, 2021
08:00am, Tuesday, 21'st Sep 2021
WALTHAM, Mass., Sept. 21, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N.
Thermo Fisher (TMO) Introduces New Automated Enzyme Analyzers
09:57am, Monday, 20'th Sep 2021
The two new Gallery Enzyme Master systems by Thermo Fisher (TMO) offer enhanced reliable enzyme analysis across several enterprises.
Why Thermo Fisher Shares Are Trading Higher Today
04:02pm, Friday, 17'th Sep 2021
Thermo Fisher Scientific Inc (NYSE: TMO) is trading higher Friday after the company issued full-year 2022 financial guidance above analyst estimates. Thermo Fisher expects full-year 2022 earnings o
Investor React Positively To Thermo Fisher's Annual Guidance
11:47am, Friday, 17'th Sep 2021
Thermo Fisher Scientific Inc (NYSE: TMO) provided initial revenue and earnings guidance for 2022 while reiterating previously disclosed financial guidance for full-year 2021. Related: Thermo Fis
Thermo Fisher's (TMO) Oncomine Dx Gets CDx Approval for EXKIVITY
11:26am, Thursday, 16'th Sep 2021
Thermo Fisher (TMO) gains FDA pre-market approval for Oncomine Dx as companion diagnostic for Takeda's EXKIVITY.
Thermo Fisher's (TMO) Oncomine Dx Gets CDx Approval From MHLW
09:56am, Wednesday, 15'th Sep 2021
Thermo Fisher's (TMO) Oncomine Dx Target Test has been approved by MHLW as a companion diagnostic for Eli Lilly and Company's selpercatinib.
Here's Why Thermo Fisher Scientific (TMO) is a Strong Growth Stock
12:50am, Saturday, 11'th Sep 2021
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Thermo Fisher Scientific to Host Virtual Investor Day
04:33pm, Thursday, 09'th Sep 2021
WALTHAM, Mass., Sept. 9, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will host a virtual Investor Day on Friday, September
Thermo Fisher (TMO)-AstraZeneca to Co-Develop NGS-Based CDx
11:32am, Monday, 06'th Sep 2021
Thermo Fisher's (TMO) new collaboration with AstraZeneca is intended to speed up development and introduction of targeted precision medicine therapies for patients.
Thermo Fisher (TMO) Gains Government Contract for Pipette Tip
10:41am, Friday, 03'rd Sep 2021
Thermo Fisher (TMO) will co-invest with the U.S. government to build a new manufacturing center for pipette tips in North Carolina.
Thermo Fisher Receives $192.5M Contract From US Govt For Pipette Tip Manufacturing
01:14pm, Thursday, 02'nd Sep 2021
Thermo Fisher Scientific Inc (NYSE: TMO) has announced a $192.5 million contract award from the U.S. Department of Defense (DoD). The contract covers the domestic production of pipette tips used wi
Thermo Fisher's (TMO) Oncomine Dx Gets CDx Approval for TIBSOVO
10:46am, Friday, 27'th Aug 2021
Thermo Fisher (TMO) receives FDA go-ahead for the Oncomine Dx Target Test as a CDx for Servier's ivosidenib tablets, TIBSOVO.
